Acute phase haemolysis in chronic cold agglutinin disease

被引:49
作者
Ulvestad, E
Berentsen, S
Mollnes, TE
机构
[1] Haukeland Univ Hosp, Gade Inst, Dept Microbiol & Immunol, N-5021 Bergen, Norway
[2] Haugesund Cty Hosp, Dept Med, Haugesund, Norway
[3] Nordland Cent Hosp, Dept Immunol & Transfus Med, Bodo, Norway
[4] Univ Tromso, N-9001 Tromso, Norway
关键词
D O I
10.1046/j.1365-3083.2001.00960.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously described a paradoxical form of chronic cold agglutinin disease (CAD) in which haemolysis occurred during episodes of fever but only marginally during exposure to colds. In order to investigate the molecular basis for this response we performed a 12-month prospective study of a patient with CAD and paradoxical haemolysis. Blood samples were collected monthly during health, and daily following hospitalization owing to hip fracture. During health we observed decreased levels of C3, undetectable C4, a non-functional classical pathway and a normal alternative pathway. Increased concentrations of C1-INH/Clrs complexes indicated continuous formation of C1-antibody-antigen complexes. There was a low-grade temperature-dependent fluctuating haemolysis as evidenced from measurements of lactate dehydrogenase. Following the hip fracture, the haemolysis increased. Levels of interleukin (IL)-1 beta, IL-6, interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha increased as did C1-INH, C3, C4, CRP, and lactate dehydrogenase. The results support our hypothesis stating that paradoxical haemolysis in CAD is controlled by the availability of early classical pathway complement molecules and that haemolysis following acute phase responses occurs as a consequence of increased complement synthesis.
引用
收藏
页码:239 / 242
页数:4
相关论文
共 10 条
[1]   No response to cladribine in five patients with chronic cold agglutinin disease [J].
Berentsen, S ;
Tjonnfjord, GE ;
Shammas, FV ;
Bergheim, J ;
Hammerstrom, J ;
Langholm, R ;
Ulvestad, E .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (01) :88-90
[2]   Chronic cold agglutinin disease of the ''idiopathic'' type is a premalignant or low-grade malignant lymphoproliferative disease [J].
Berentsen, S ;
Bo, K ;
Shammas, FV ;
Myking, AO ;
Ulvestad, E .
APMIS, 1997, 105 (05) :354-362
[3]   A neoepitope-based enzyme immunoassay for quantification of C1-inhibitor in complex with C1r and C1s [J].
Fure, H ;
Nielsen, EW ;
Hack, CE ;
Mollnes, TE .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (06) :553-557
[4]   INHIBITION OF COMPLEMENT-MEDIATED RED-CELL LYSIS BY IMMUNOGLOBULINS IS DEPENDENT ON THE IG-ISOTYPE AND ITS CL BINDING-PROPERTIES [J].
MOLLNES, TE ;
HOGASEN, K ;
HOAAS, BF ;
MICHAELSEN, TE ;
GARRED, P ;
HARBOE, M .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (05) :449-456
[5]  
MOLLNES TE, 1997, WEIRS HDB EXPT IMMUN, V78, P1
[6]   C1 INHIBITOR AND DIAGNOSIS OF HEREDITARY ANGIOEDEMA IN NEWBORNS [J].
NIELSEN, EW ;
JOHANSEN, HT ;
HOLT, J ;
MOLLNES, TE .
PEDIATRIC RESEARCH, 1994, 35 (02) :184-187
[7]  
Ulvestad E, 1999, EUR J HAEMATOL, V63, P259
[8]  
Ulvestad E, 1998, EUR J HAEMATOL, V60, P93
[9]  
VOLANAKIS JE, 1995, ANNU REV IMMUNOL, V13, P11
[10]   APPLICATION OF A MONOCLONAL-ANTIBODY AGAINST A NEOEPITOPE ON ACTIVATED C4 IN AN ELISA FOR THE QUANTIFICATION OF COMPLEMENT ACTIVATION VIA THE CLASSICAL PATHWAY [J].
WOLBINK, GJ ;
BOLLEN, J ;
BAARS, JW ;
TENBERGE, RJM ;
SWAAK, AJG ;
PAARDEKOOPER, J ;
HACK, CE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 163 (01) :67-76